iiinova — where your digital self keeps evolving

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 16/07/2025

🌟 ABX Pearl of the Day: penicillin allergies ❓ Q: My patient reports a reaction to penicillin (acute, self-limited rash) over 10 years ago. Can they safely receive cefazolin for their MSSA infection? #IDsky #medsky #meded #pharmsky #skyRX #AMSsky

1118

Reposted by Caitlin Ellis

Society of Infectious Diseases Pharmacists - SIDP @sidpharm.bsky.social · 11/07/2025

Check out a new series in Clinical Infectious Diseases: Clinical Dilemmas in Infectious Diseases📑 This section features clinical problem-solving exercises presented by a discussant unpacking treatment decisions as the case unfolds. 🧵1/2

1116

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 09/07/2025

🌟 ABX Pearl of the Day: sputum interpretation ❓ Q: My patient has 4+ growth of an organism on respiratory culture. Does this mean he has pneumonia? #IDsky #medsky #meded #pharmsky #skyRX #AMSsky

141

Reposted by Caitlin Ellis

Betsy Hirsch, PharmD (TLOAS) @ebhirsch.bsky.social · 03/06/2025

Breakpoint updates from #CLSI for Acinetobacter spp. 📌Tetracycline urine breakpoint was removed based on absence of data to support. Doxycycline removed in Jan 2025 and minocycline breakpoint lowered #MedSky #IDSky

Tetracycline and Acinetobacter breakpoints in table format

172

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 28/05/2025

🌟 ABX Pearl of the Day: revisiting Vancomycin Zosyn nephrotoxicity ❓ Q: Is the combination of vancomycin and piperacillin-tazobactam safe for the kidneys? #IDsky #medsky #meded #pharmsky #skyRX

1114

Reposted by Caitlin Ellis

MAD-ID The Antimicrobial Stewardship Meeting @mad-id.bsky.social · 28/05/2025

📣 Attention Program Directors! Sign up is OPEN! 🌟 MAD-ID is excited to spotlight your PGY2 ID pharmacy residency or ID pharmacy fellowship program in the upcoming academic year! 🎓 See eligibility criteria! Sign up: forms.office.com/r/86HfX98XqT @SIDPharm.bsky.social @accpinfdprn.bsky.social

023

Reposted by Caitlin Ellis

MAD-ID The Antimicrobial Stewardship Meeting @mad-id.bsky.social · 28/05/2025

🥳 Official programming for #MADID2025 kicks off today with interactive workshops! 🤓 🍄 Fungal stewardship, 📈 NHSN AR, 🤖 AI in stewardship education, and 💊 New Antibiotic Formulary Decisions! @sidpharm.bsky.social @accpinfdprn.bsky.social @contagionlive.bsky.social

134

Caitlin Ellis @caitjellis.bsky.social · 22/05/2025

Couldn’t let the day go by without wishing a happy ID Pharmacist Day to all my fellow ID pharmies out there! 🦠🧫💊 I sure love what I do, and even in the tough days (#iykyk), I couldn’t imagine doing anything else!

061

Reposted by Caitlin Ellis

MAD-ID The Antimicrobial Stewardship Meeting @mad-id.bsky.social · 22/05/2025

Today, May 22, is Infectious Diseases Pharmacists Day! Join the @sidpharm.bsky.social Bluesky chat from 11–12 noon CDT today and use the hashtag #IDPharmacistsDay to recognize the importance of ID pharmacists in patient care

0127

Reposted by Caitlin Ellis

ACCP ID PRN @accpinfdprn.bsky.social · 20/05/2025

Nothing is better than seeing this study published just in time for ID Pharmacists Day! 🥳 #IDSky

0224

Reposted by Caitlin Ellis

Society of Infectious Diseases Pharmacists - SIDP @sidpharm.bsky.social · 20/05/2025

Infectious Diseases Pharmacists Day is Thursday! Join the chat here 5/22 12-1PMEST help us celebrate the amazing work ID pharmacists do every day. #IDPharmacistsDay, #SIDPAdvocacy, #PharmacistsLeadingChange @sidpharm.bsky.social @accpinfdprn.bsky.social

02010

Reposted by Caitlin Ellis

Society of Infectious Diseases Pharmacists - SIDP @sidpharm.bsky.social · 20/05/2025

To kick off a new series ID/AMS Reading Lists series, SIDP is here to help you "Hit 'Em with Your Best Nudge"! Check out this noticeable (and unnoticed) nudge comments in AMS! #IDSky #rxsky #pharmsky #AMSsky #medsky #SIDP #EvidenceBasedMedicine #IDPharmacy #Microbiology #Nudge #NudgeComments

0208

Reposted by Caitlin Ellis

Contagion® @contagionlive.bsky.social · 20/05/2025

Innoviva Specialty Therapeutics’ antibiotic is the first and only FDA-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia, including right-sided endocarditis, caused by the methicillin-resistant Staphylococcus aureus. #IDsky #Medsky

contagionlive.com

Ceftobiprole Launches Commercially in US

Innoviva Specialty Therapeutics’ antibiotic is the first and only FDA-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by th...

062

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 08/05/2025

🌟 ABX Pearl of the Day: Positive UCx but unable to verbalize UTI symptoms ❓ Q: My elderly patient had a fall with altered mental status, and UCx is growing pan-S E. coli (>100K CFU/mL). They are unable to verbalize UTI symptoms. Should I treat for UTI? #IDsky #medsky #meded #pharmsky #skyRX

174

Reposted by Caitlin Ellis

Jonathan Ryder, MD @jonathanrydermd.bsky.social · 30/04/2025

My latest for @contagionlive.bsky.social on the lastest data about cellulitis epidemiology and how we can use that to update our treatment paradigms! #IDSky

1177

Reposted by Caitlin Ellis

Erin McCreary, PharmD @erinmccreary.bsky.social · 12/04/2025

@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025 fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA

27633

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 07/04/2025

🌟 ABX Pearl of the Day: Candida in urine cx💊 ❓ Q: My patient is growing Candida albicans in his urine, do I need to treat him? #IDsky #medsky #meded #pharmsky #skyRX

184

Reposted by Caitlin Ellis

ACCP ID PRN @accpinfdprn.bsky.social · 14/03/2025

ID PRN and SIDP members 📣📣 Are you or your team presenting at at ESCMID Global or the SHEA Spring Meeting this year?! If so, fill out this quick survey by Tues, April 1 so we can recognize your accomplishments and show off your hard work ‼️🔬🧪 #IDSky docs.google.com/forms/d/e/1F...

001

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 14/03/2025

🌟 ABX Pearl of the Day: bilateral LE erythema = cellulitis? ❓ Q: What are common mimickers of cellulitis? #IDsky #medsky #meded #pharmsky #skyRX

182

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 13/03/2025

🌟 ABX Pearl of the Day: Nasal MRSA PCR in pneumonia💊 ❓ Q: If my patient with pneumonia has a positive MRSA nasal PCR but respiratory cultures are negative for MRSA, do I need to continue vancomycin for a full course of therapy? #IDsky #medsky #meded #pharmsky #skyRX

164

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 25/02/2025

🌟 ABX Pearl of the Day: Yeast coverage in intra-abdominal infections 💊 📋 Q: My patient has an intra-abdominal infection. Should I add empiric coverage for yeast? What if they have a gastrointestinal perforation? #IDsky #medsky #meded #pharmsky #skyRX

1123

Reposted by Caitlin Ellis

ACCP ID PRN @accpinfdprn.bsky.social · 20/02/2025

Have you seen the news?! 🥳 The long awaited cUTI guidelines are up for comments! 🤓📚 🔗: www.idsociety.org/practice-gui... Check it out & be sure to get your comments in by March 19, 2025 @ 5pm! #IDSky #PharmSky

idsociety.org

Complicated Urinary Tract Infections

01710

Reposted by Caitlin Ellis

Betsy Hirsch, PharmD (TLOAS) @ebhirsch.bsky.social · 20/02/2025

‼️The @idsainfo.bsky.social cUTI guideline 📄 draft is now available for public comment🗣️! This version has been reviewed by 15+ orgs & revised according to extensive feedback provided to us. www.idsociety.org/practice-gui... UTIsky IDsky Medsky PharmSky

Screenshot of IDSA cUTI guideline open for public comment

Draft of IDSA cUTI guideline showing steps to follow for selection of therapy

Figure 2 flowchart showing stepwise assessment of IV to PO switch and duration of therapy

Figure showing old vs new definition of uUTI, cUTi, and acute pyelonephritis

54422

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 10/02/2025

🌟 ABX Pearl of the Day: Febrile neutropenia (FN)- vancomycin de-escalation 💊 📋 Q: ❓ Q: I started vancomycin + cefepime for a patient with FN admitted with shock. On day 3, no pressors, cultures are negative, unclear source. Can I discontinue vancomycin? #IDsky #medsky #meded #pharmsky #skyRX

1125

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 13/01/2025

🌟 ABX Pearl of the Day: Susceptible-Dose Dependent (SDD) 💊 📋 Q: What does it mean when the lab reports my isolate as being “susceptible-dose dependent” (SDD)? #IDsky #MedSky #PharmSky

183

Caitlin Ellis @caitjellis.bsky.social · 08/01/2025

#IDSky I need your insight/opinion/data! 🧐 Do you have a rule/guidance in regard to how much of a pre-op antibiotic should be infused prior to surgery? (I.e at least 50%, 80%, etc.) 🔪💉💊 I know best practice would be all but if you were in a crunch….

130

Caitlin Ellis @caitjellis.bsky.social · 08/01/2025

The ID PRN has made its way to BlueSky! Check out the account ⬇️ and be sure to check out the journal club on Friday! 📚🤓🦠 #IDSky

051

Caitlin Ellis @caitjellis.bsky.social · 09/12/2024

Continuing day 2 of ASHP Midyear 24 with @dhpharmd.bsky.social & Dr. Manasco discussing updates in treatment of GN bacterial infxns! 🤓🦠 can’t beat a good coverage table 👏🏼 #IDSky #PharmSky

091

Caitlin Ellis @caitjellis.bsky.social · 08/12/2024

Kicking off Midyear 2024 with this great pro/con debate between @floralquinolone.bsky.social & Dr. Nguyen 🤩 Are you team clinda or team linezolid for NSTIs?! 🤔 #IDsky #PharmSky

2121

Reposted by Caitlin Ellis

Society of Infectious Diseases Pharmacists - SIDP @sidpharm.bsky.social · 25/11/2024

Check out the latest edition of SIDP & Contagion Live's Bench to Bedside Series focused on Echinocandin dosing in obesity from experts, Drs. Taryn Eubank and David Ha! Read here: buff.ly/3ZlSPHe

262

Reposted by Caitlin Ellis

Arkansas Antimicrobial Stewardship Foundation @arstewardship.bsky.social · 21/11/2024

Bacteria help each other out! Let's do the same. Antibiotic exposure is a leading risk for antimicrobial resistance. Learn when antibiotics are unnecessary to help combat resistant infections in our community. #USAAW24 #BeAntibioticsAware #ItTakesAllofUs #ARstewardship

153

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 20/11/2024

🌟 ABX Pearl of the Day: Best practices for Tx of uncomplicated GNR bacteremia💊 📋 Q: My patient presented with septic shock from a urinary source, blood cultures positive for E. coli. What is the duration of therapy, and must I use IV to complete the course for Enterobacterales bacteremia? 🤔 #IDsky

33815

Reposted by Caitlin Ellis

Society of Infectious Diseases Pharmacists - SIDP @sidpharm.bsky.social · 19/11/2024

In celebration of #USAAW24, check out our Clinician Blog Series available here: sidp.org/Antibiotic-A... Viewpoints on the fight against AR from physicians, infection prevention, & pharmacist perspectives highlighting the vital role of a team-based approach to optimize care! 🦠🧫💊

097

Reposted by Caitlin Ellis

Erin McCreary, PharmD @erinmccreary.bsky.social · 18/11/2024

happy #antibioticawarenessweek!🦠 sharing a paper I ❤️ from Dr. Dinh, a lovely human who told me they noticed in their RCTs that some patients were getting exclusive PO treatment for CAP (dealers choice!) They explored these pts and its worth a read #idsky #pharmsky pubmed.ncbi.nlm.nih.gov/38734138/

pubmed.ncbi.nlm.nih.gov

Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial - PubMed

This trial is registered with ClinicalTrials.gov, NCT01963442.

1349

Reposted by Caitlin Ellis

MAD-ID The Antimicrobial Stewardship Meeting @mad-id.bsky.social · 15/11/2024

🎉 Save the Date! 📅 The 27th Annual MAD-ID Meeting is happening May 28-31, 2025, in sunny Orlando, FL! 🌴✨ Join us for an opportunity to connect, learn, and collaborate with experts in infectious diseases. Stay tuned for more details! 🌟 #MADID2025 #IDSky #MedSky #PharmSky

buff.ly

Annual Meeting | MAD-ID.org

MAD-ID offers an Annual Meeting where pharmacists, physicians, nurses and other healthcare providers will be given the opportunity to participate in this three-and-a-half-day educational program…

0157

Reposted by Caitlin Ellis

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 15/11/2024

🩺 ABX Pearl of the Day: Interpreting Single BCx GPC/GPR Q: I got an alert that my patient’s blood culture is positive for GPCs. How do I know if it's a contaminant? 🤔 A: It can be tricky, especially in critically ill patients. Let’s break it down! 👇 #IDsky #Medsky #RXsky #Pharmsky #MedEd #AMSsky

34612

Reposted by Caitlin Ellis

Erin McCreary, PharmD @erinmccreary.bsky.social · 11/11/2024

for our new #IDsky #Medsky friends, @sidpharm.bsky.social creates an ID & stewardship podcast called Breakpoints. here’s one of my favorite episodes featuring the amazingly smart and kind Robert Bonomo and Ryan Shields teaching us all things enzymatic resistance podcasts.apple.com/us/podcast/b...

podcasts.apple.com

A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2

Podcast Episode · Breakpoints · 10/29/2021 · 1 sec

28525

Reposted by Caitlin Ellis

MAD-ID The Antimicrobial Stewardship Meeting @mad-id.bsky.social · 11/11/2024

Hello #IDSky #MedSky #PharmSky! We are MAD-ID, striving to educate 🎓 and promote 🏆 infectious diseases and antimicrobial stewardship clinicians and researchers! Looking forward to the bright future of our ID community on this platform 🦋

2328

Caitlin Ellis @caitjellis.bsky.social · 10/11/2024

Hello #PharmSky #IDSky! I’m Caitlin, an ID pharmacist in San Diego, CA. ☀️ My ID assistant and I are very excited about what’s to come on this app. 🐶🤓🦠 Looking forward to connecting with everyone!

4726